Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I.
about
Behavioral and psychological symptoms of dementiaThe merits and problems of Neuropsychiatric Inventory as an assessment tool in people with dementia and other neurological disordersThe association between physical morbidity and subtypes of severe depressionInvestigational drugs for treating agitation in persons with dementia.Individual music therapy for managing neuropsychiatric symptoms for people with dementia and their carers: a cluster randomised controlled feasibility study.Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer's disease and frontotemporal lobar degenerationImpact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study.Cortical brain volume abnormalities associated with few or multiple neuropsychiatric symptoms in Alzheimer's diseaseFunctional assessment and neuropsychiatric inventory questionnaires: measurement invariance across hispanics and non-Hispanic whitesBehavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment.Obesity and Co-morbid Conditions Are Associated with Specific Neuropsychiatric Symptoms in Mild Cognitive ImpairmentTranscranial direct current stimulation for depression in Alzheimer's disease: study protocol for a randomized controlled trial.Review of cerebral microangiopathy and Alzheimer's disease: relation between white matter hyperintensities and microbleeds.Neuropsychiatric symptoms in Alzheimer's disease are related to functional connectivity alterations in the salience network.Total cholesterol and neuropsychiatric symptoms in Alzheimer's disease: the impact of total cholesterol level and gender.Initial and long-term evaluation of patients with Alzheimer's after hospitalization in cognitive and behavioural units: the EVITAL study designNeuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene.Proinflammatory cytokines, sickness behavior, and Alzheimer diseaseAttenuation of neuropsychiatric symptoms and caregiver burden in Alzheimer's disease by motor intervention: a controlled trial.Cerebral correlates of psychotic syndromes in neurodegenerative diseasesUse of anti-dementia drugs in home care and residential care and associations with neuropsychiatric symptoms: a cross-sectional studyPrinciples and management of neuropsychiatric symptoms in Alzheimer's dementiaThe 5-HTTLPR variant in the serotonin transporter gene modifies degeneration of brain regions important for emotion in behavioral variant frontotemporal dementia.Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET).The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.Predictors for Nursing Home Admission and Death among Community-Dwelling People 70 Years and Older Who Receive Domiciliary Care.Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum.The impact of dementia on the use of general practitioners among the elderly in NorwayAn initial study of modifiable and non-modifiable factors for late-life psychosis.Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer's diseasePrevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients.The influence of caregivers and behavioral and psychological symptoms on nursing home placement of persons with Alzheimer's disease: A matched case-control study.The Brazilian version of the Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity in dementia.Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease.Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease.Management of behavioral problems in Alzheimer's disease.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias.Clinicopathological correlates of behavioral and psychological symptoms of dementia.Behavioral and psychological subsyndromes in Alzheimer's disease using the Neuropsychiatric Inventory.
P2860
Q21129432-771AEE90-1331-4672-9748-BB5E010B26DBQ26823480-CFBB27B4-E709-4204-8E86-3E05303D390AQ28279182-0665AFF3-57DC-4376-AA3B-9E18463279DAQ30250076-39F730B2-4230-4931-AD72-5DC7DEC51DE8Q30376806-652A4AE9-3701-4973-B2C4-E05837BE44A5Q30412009-79F7DA65-89A8-4DAD-B9B4-8D417BD4E158Q30600808-08D96D47-4E95-42BA-B31A-980FAA4BDF9CQ33649293-1D03475F-6C8E-4BE1-84CD-6C4F594A0BBFQ33652274-C028187A-A11A-4D02-92F4-03B69D9BAAD8Q33709765-37A4A28E-F9B3-48F3-81FD-0CEABE45D5FDQ33734627-08C280FE-E3BC-4CD1-AEAD-11DFE90970AFQ33815141-B135F021-CE0B-4076-AE2E-1C49E4DCF693Q34149357-C350302C-CCF1-4FA7-A63C-4900B5CE08A8Q34328295-1F293A55-01E0-40A9-B3BA-EF5E34C27DEEQ34364200-6E24F3B8-3C1D-4521-9DC2-E8F5B1D5A32EQ34551466-D43CC468-28D0-4B80-98A4-87619B577C59Q34953672-34B1D38C-6EF3-41AB-968F-0DCC3D3D7737Q35104455-7CA6E315-E8DC-4F98-A3CD-8DDAE0630FC8Q35179688-C50F0CA2-281B-42A7-BB11-F62EFF9C4815Q35194993-6BC5117B-07B4-4AD3-9929-5DDBAD3BD1AAQ35744523-482AA84C-3312-4020-AF61-74D5360C2356Q36063264-270A2DCF-54AB-4E5A-AADA-30BF2D0FA2FDQ36076935-F9F1EF97-1A9D-41A6-8155-D290E0300A0FQ36109984-D291BF76-A5F9-489E-A1EF-6BB05EF1E9DBQ36149767-E73ABA22-A9AC-4FB0-BAEC-DA515EF81F6FQ36170664-431AF029-B957-40B6-AE67-6CCDA2EDB2DFQ36547529-B8721EA9-838C-4FEC-96EA-8B713300139FQ36572028-C7E97FA6-9FA8-4629-9B3A-098C37FC2D32Q36765671-CD91EE53-FCEF-4CBA-8E29-DE2E9ABF77E3Q36780771-727441FC-8CA6-48D2-95DE-BED4756D220BQ36966064-8C33B915-EBE7-4128-AF5F-B519CD29A1D2Q37208851-3544EFBD-C0D6-47BB-A63E-A0B1AD5EEB2AQ37527142-73AADE9E-00B6-40AD-968D-E8603734033DQ37555160-9CE5CF65-D390-4006-B4E6-261A1E7EF97FQ37610213-CA9850F9-F095-428B-8706-DCFD3D5FDC2AQ37639155-7CFE2319-449E-4CCD-9E5C-64E29BF42725Q37680018-56D2A10D-8011-4380-8BCC-6F2C3BF93376Q37834619-1C85D777-6A7E-4605-90E4-F1CF01FEF8E7Q37860194-A95E77C0-A1B6-4A37-A155-4FE57936AAADQ38059401-3318BE52-C4D2-40B3-B678-5694BBABE8EE
P2860
Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Neuropsychiatric syndromes in ...... er Disease Consortium: part I.
@en
type
label
Neuropsychiatric syndromes in ...... er Disease Consortium: part I.
@en
altLabel
Neuropsychiatric Syndromes in Dementia
@en
prefLabel
Neuropsychiatric syndromes in ...... er Disease Consortium: part I.
@en
P2093
P2860
P50
P356
P1476
Neuropsychiatric syndromes in ...... er Disease Consortium: part I.
@en
P2093
Anna Marriott
Debby Collins
Eleanor Jane Byrne
Frans R J Verhey
Giovanni Frisoni
Kazi Elina
Marina Boziki
Miriam Caputo
Nicola Girtler
Pauline Aalten
P2860
P304
P356
10.1159/000110738
P407
P50
P577
2007-11-07T00:00:00Z